Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer Sells 12,000 Shares

Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer sold 12,000 shares of the business’s stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $2.85, for a total transaction of $34,200.00. Following the completion of the transaction, the chief executive officer now directly owns 9,036,886 shares of the company’s stock, valued at approximately $25,755,125.10. This represents a 0.13 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Mark Newcomer also recently made the following trade(s):

• On Tuesday, January 21st, Mark Newcomer sold 61,000 shares of Paysign stock. The shares were sold at an average price of $2.89, for a total transaction of $176,290.00.
• On Monday, December 9th, Mark Newcomer sold 41,000 shares of Paysign stock. The stock was sold at an average price of $3.31, for a total value of $135,710.00.
• On Wednesday, November 20th, Mark Newcomer sold 25,000 shares of Paysign stock. The stock was sold at an average price of $3.27, for a total value of $81,750.00.
• On Monday, November 18th, Mark Newcomer sold 40,000 shares of Paysign stock. The shares were sold at an average price of $3.24, for a total value of $129,600.00.

Paysign Stock Up 1.4 %

NASDAQ PAYS traded up $0.04 on Thursday, reaching $2.90. The company had a trading volume of 196,394 shares, compared to its average volume of 321,771. Paysign, Inc. has a 52 week low of $2.70 and a 52 week high of $5.59. The stock has a market cap of $155.30 million, a price-to-earnings ratio of 19.33 and a beta of 0.95. The stock’s 50 day moving average is $3.16 and its 200-day moving average is $3.91.

Paysign (NASDAQ:PAYS) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.02. The business had revenue of $15.26 million for the quarter, compared to the consensus estimate of $14.96 million. Paysign had a net margin of 14.28% and a return on equity of 30.64%. During the same period last year, the company posted $0.02 EPS. As a group, analysts forecast that Paysign, Inc. will post 0.21 EPS for the current year.

Hedge Funds Weigh In On Paysign

Hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of New York Mellon Corp raised its stake in Paysign by 5.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 85,964 shares of the company’s stock worth $371,000 after buying an additional 4,248 shares during the period. Rhumbline Advisers raised its position in shares of Paysign by 25.1% during the second quarter. Rhumbline Advisers now owns 35,835 shares of the company’s stock worth $154,000 after purchasing an additional 7,190 shares during the period. American Century Companies Inc. acquired a new stake in shares of Paysign during the second quarter worth about $92,000. Dimensional Fund Advisors LP grew its position in shares of Paysign by 51.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 116,779 shares of the company’s stock valued at $502,000 after purchasing an additional 39,710 shares during the period. Finally, Renaissance Technologies LLC grew its position in shares of Paysign by 25.0% in the 2nd quarter. Renaissance Technologies LLC now owns 1,504,380 shares of the company’s stock valued at $6,484,000 after purchasing an additional 301,000 shares during the period. 25.89% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have weighed in on PAYS shares. Barrington Research reissued an “outperform” rating and set a $7.00 price objective on shares of Paysign in a report on Monday, November 4th. Lake Street Capital initiated coverage on shares of Paysign in a research note on Friday, December 20th. They set a “buy” rating and a $6.00 price target for the company.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.